- Home
- GCTS vs NSRX Comparison
GCTS vs NSRX Comparison
Compare GCTS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCTS | NSRX |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5M | 53.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GCTS | NSRX |
|---|---|---|
| Price | $1.29 | $2.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $3.50 | ★ $20.50 |
| AVG Volume (30 Days) | ★ 1.3M | 134.1K |
| Earning Date | 03-25-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,239.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $2.40 |
| 52 Week High | $2.47 | $9.99 |
Technical Indicators
Market Signals| Indicator | GCTS | NSRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.32 | 25.37 |
| Support Level | $1.26 | N/A |
| Resistance Level | $1.48 | $5.20 |
| Average True Range (ATR) | 0.07 | 0.41 |
| MACD | 0.02 | -0.21 |
| Stochastic Oscillator | 86.52 | 4.64 |
Price Performance
Historical ComparisonAbout GCTS GCT Semiconductor Holding Inc.
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.